Abstract
Values of IGF-I after extraction, its binding proteins, and the high affinity GH-binding protein (BP) are not well established in pediatric patients with insulin-dependent diabetes mellitus (IDDM). We report data for IGF-I, IGFBP-1 and -3, and GHBP in 92 Spanish children with IDDM, separated according to pubertal stage: prepubertal (n = 49); pubertal onset(n = 17); mid-puberty (n = 17), and complete puberty(n = 9), as well as to metabolic control (HbA1 <9% or≥9%). IGF-I levels in IDDM patients increased throughout development(p < 0.001), but were diminished at every developmental stage when compared with matched control subjects. IGF-I concentrations showed a negative correlation with the degree of metabolic control, in particular during the prepubertal stage of development. A negative correlation(r = -0.22; p < 0.005) between IGF-I concentrations and HbA1 was found. Serum IGFBP-1 levels diminish during maturation in diabetic patients (p < 0.001). However, IDDM patients have significantly higher levels of IGFBP-1 than control subjects at every stage of development, and IDDM patients with inadequate metabolic control exhibit even greater differences when compared with matched control subjects. A positive correlation (r = 0.22; p < 0.005) between IGFBP-1 concentrations and HbA1 was found. IGFBP-3 serum levels were similar to those observed in normal subjects, and no correlation was observed in relation to the metabolic control. In IDDM patients, GHBP levels change significantly during maturation, as they do in normal control subjects; however, significantly lower GHBP levels were found in prepubertal and pubertal IDDM patients. GHBP levels were independent of metabolic control, although a tendency toward lower levels of GHBP was seen when HbA1 levels increased. We suggest that a partial GH resistance syndrome exists in IDDM patients, and this may be related to the metabolic control. Hence, the biochemical markers measured here may be of value in evaluating the smaller pubertal growth spurt in diabetic patients.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- IDDM:
-
insulin-dependent diabetes mellitus
- BP:
-
binding protein
- BMI:
-
body mass index
- ANOVA:
-
analysis of variance
References
Serrano Rios M, Moy CS, Martin Serrano R, Minuesa A, Tomas ME, Zarandieta G, Herrera J 1990 Incidence of type I diabetes mellitus in subjects 0:14 years of age in the Comunidad of Madrid, Spain. Diabetologia 33: 422–425.
Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV 1986 Impaired insulin action in puberty: a contributing factor to poor glycaemic control in adolescents with diabetes. N Engl J Med 315: 215–219.
Baxter RC, Martin JL 1989 Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1: 49–68.
Cohen P, Fielder PJ, Hasegawa Y, Frish H, Giudice LC, Rosenfeld RG 1991 Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol 124: 74–85.
Daughaday WH, Trivedi B 1991 Clinical aspects of growth hormone binding proteins. Acta Endocrinol 124: 27–32.
Holly JMP 1991 The physiological role of IGFBP-1. Acta Endocrinol 124: 55–62.
Holly JMP, Biddlecombe RA, Dunger DB 1988 Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin?. Clin Endocrinol 29: 667–675.
Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC 1986 A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 62: 134–141.
Herington AC, Ymer S, Stevenson J 1986 Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 77: 1817–1823.
Baumann G, Shaw MA 1990 A second, lower affinity growth hormone binding protein in human plasma. J Clin Endocrinol Metab 70: 680–686.
Tanner JM 1962 Growth and Adolescence, 2nd Ed. Blackwell Scientific Publications, Oxford
Argente J, Barrios V, Pozo J, Muñoz MT, Hervás F, Stene M, Hernández M 1993 Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age and sex related changes. J Clin Endocrinol Metab 77: 1522–1528.
Hernández M, Castellet J, Narvaíza JL, Rincón JM, Ruiz I, Sanchez E, Sobradillo B, Zurimendi A 1988 In: Hernández M, Fundación F. Orbegozo (eds) Curvas y tablas de crecimiento. Editorial Garsi, Madrid
Vanelli M, Fanti A, Adinolfi B, Ghizzoni L 1992 Clinical data regarding the growth of diabetic children. Horm Res 37( suppl): 65:669.
Dunger DB 1992 Diabetes in puberty. Arch Dis Child 67: 569–573.
Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP 1990 Increased overnight growth hormone concentrations in diabetes compared with normal adolescents. J Clin Endocrinol Metab 71: 1356–1362.
Nieves-Ribera F, Rogol A, Veldhuis JD, Branscon DK, Martha PM, Clarke WL 1993 Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77: 638–643.
Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV 1984 Effect of diabetes and its control on insulin-like factors in the young subject with type I diabetes. Diabetes 33: 1175–1179.
Merimee TJ, Zapf J, Froesch ER 1983 Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med 309: 527–530.
Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78: 744:75752
Taylor AM, Dunger DB, Grant DB, Preece MA 1988 Somatomedin-C/IGF-I measured by RIA and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls. Diabetes Res 9: 177–181.
Blethen SL, Sargeant DT, Whitlow MG, Santiago JV 1981 Effect of pubertal stage and recent blood glucose control on plasma somatomedin C in children with insulin-dependent diabetes mellitus. Diabetes 30: 868–872.
Bach JA, Baxter RC, Werther G 1991 Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 73: 964–968.
Baxter RC 1993 Circulating binding proteins for the insulin like growth factors. Trends Endocrinol Metab 4: 91–96.
Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Waas JAH, Patel S, Tate VE 1990 The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-1 inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol 32: 229–239.
Cheetham TD, Jones J, Taylor AM, Holly JP, Matthews DR, Dunger DB 1993 The effects of recombinant insulin-like growth factor-I administration on growth hormone levels and insulin requirements in adolescents with type I (insulin-dependent) diabetes mellitus. Diabetologia 36: 678–681.
Amiel SA, Caprio S, Sherwin RS, Pleeve G, Haymond MW, Tamborlane WV 1991 Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 72: 277–282.
Edge JA, Matthews DR, Dunger DB 1990 Failure of current insulin-regimens to meet the overnight requirements of adolescents with insulin-dependent diabetes. Diabetes Res 15: 109:11112
Beaufrere B, Beylot M, Metz C, Ruitton A, Francois R, Riou JP, Mornex R . 1988 Down phenomenon in type I (insulin dependent) diabetic adolescents: influence of nocturnal growth hormone secretion. Diabetologia 31 607: 611
Lee PD, Conover CA, Powell DR 1993 Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204: 4–29.
Rieu M, Binoux M 1985 Serum levels of insulin-like growth factors (IGF) and IGF binding protein in insulin-dependent diabetes during an episode of severe metabolic descompensation and the recovery phase. J Clin Endocrinol Metab 60: 781–785.
Barrios V, Argente J 1993 Aspectos metodológicos y utilidad diagnóstica de la proteina transportadora de los factores de crecimiento similares a la insulina-3 (IGFBP-3). Endocrinologia 40: 133–136.
Brismar K, Fernquist-Forbes E, Wahen J, Hall K 1994 Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3 and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 79: 872–878.
Menon RK, Arslanian S, May B, Cutfield WS, Sperling MA 1992 Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 74: 934–938.
Massa G, Dooms L, Bouillon R, Vanderschueren-Lodewey CKX M 1993 Serum levels of growth hormone binding-protein and insulin like growth factor I in children. Diabetologia 36: 239:243
Holl RW, Setgler B, Scherbaum WA, Heinze E 1993 The serum growth hormone-binding protein is reduced in young patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76: 165–167.
Clayton KL, Holly JM, Carlsson LMS, Jones J, Cheetham TD, Taylor AM, Dunger DB 1994 Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus. Clin Endocrinol 41: 517–524.
Baumann G, Shaw MA, Amburn K 1989 Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism 38: 683–689.
Giustina A, Wehrenberg WB 1994 Growth hormone neuroregulation in diabetes mellitus. Trends Endocrinol Metab 5: 73–78.
Acknowledgements
The authors thank Dr. Julie A. Chowen for the critical review of the manuscript.
Author information
Authors and Affiliations
Additional information
Supported by Fundación Endocrinología y Nutrición.
This work was presented in part at the 36th Annual Meeting of the Spanish Society of Endocrinology in Sevilla, Spain, and reported in abstract from (Endocrinología 1993;40:26).
Rights and permissions
About this article
Cite this article
Muñoz, M., Barrios, V., Pozo, J. et al. Insulin-Like Growth Factor I, Its Binding Proteins 1 and 3, and Growth Hormone-Binding Protein in Children and Adolescents with Insulin-Dependent Diabetes Mellitus: Clinical Implications. Pediatr Res 39, 992–998 (1996). https://doi.org/10.1203/00006450-199606000-00011
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199606000-00011
This article is cited by
-
Growth Hormone and Counterregulation in the Pathogenesis of Diabetes
Current Diabetes Reports (2022)
-
Renal effects of growth hormone in health and in kidney disease
Pediatric Nephrology (2021)
-
Insulin does not rescue cortical and trabecular bone loss in type 2 diabetic Goto-Kakizaki rats
The Journal of Physiological Sciences (2018)
